4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-012237
EVP, CHIEF FINANCIAL OFFICER sold 3,503 shares at $16.94 ($59,341)
- EVP, CHIEF FINANCIAL OFFICER acquired 6,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-05-01 | Option exercise | +6,814 | 35,556 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-05-02 | Sale | −3,503 | $16.94 | $59,341 | 32,053 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-05-01 | Option exercise · Restricted Stock Units | −6,814 | 20,445 | D | ||
| Open-market sales · 3,503 sh · avg $16.94 · $59,341 | |||||||
Loading xslF345X05/form4-05032024_060510.xml…